News | Stereotactic Body Radiation Therapy (SBRT) | December 23, 2015

PetCure Oncology's Cancer Treatment Brings Family Pet Home for the Holidays

Five hundred-mile journey from Birmingham to Cincinnati saves Boxer from fatal brain tumor

PetCure Oncology, stereotactic radiosurgery, SRS, Laura Leal, Cincinnati

Pet owner Laura Leal and her beloved Boxer Addy, join Kelli Sloane, radiation therapist, after successful treatment of Addy's brain tumor with stereotactic radiosurgery (SRS) at PetCure Oncology at Care Center in Cincinnati. Photo courtesy of Business Wire

December 23, 2015 — What is the connection between a family in Birmingham, Ala., and a veterinary cancer care team in Cincinnati, Ohio, over 500 miles away? Addy, an 11-year-old Boxer diagnosed with a life-threatening brain tumor, and a dedicated pet owner on a mission to save her furry family member.

With the help of PetCure Oncology at Care Center, pet owner Laura Leal and her beloved Addy will be able to enjoy some extra cheer this holiday season.

Laura and Addy have been an inseparable pair for more than a decade. Laura, a registered nurse, credits her medical training in keeping Addy healthy over the years. This past September, Addy began having seizures. With support and guidance from their Birmingham-based primary-care veterinarian, Addy was referred to a veterinary specialist and a computed tomography (CT) scan was performed.

She was diagnosed with a brain tumor and given weeks or maybe months to live if nothing was done. The recommended treatment was surgery to remove as much of the tumor as possible followed by 30 days of standard radiation therapy (RT). Laura understood the ramifications of the diagnosis but was uncomfortable with the recommendation. Hoping to avoid the lengthy treatment program and undesirable side effects that accompany standard radiation therapy, she wondered if there might be an alternate course of action.

Laura found hope in an emerging new cancer treatment called stereotactic radiosurgery (SRS). She was pointed in the right direction by a friend who had recently attended a lecture that mentioned a study being done on dogs with brain tumors. With that in mind, she began to research the topic online and came across Neal Mauldin, DVM, DACVIM (internal medicine and oncology), DACVR (RO), a leading expert in veterinary SRS and the chief medical officer at PetCure Oncology.

SRS is an advanced form of radiation therapy that has a long history of success in human medicine but has just recently become available to pets suffering from cancer. SRS offers significant benefits over traditional RT by:

  • Offering a treatment with the intent to cure cancer rather than just ease symptoms;
  • Minimizing both the risks and side effects commonly associated with RT;
  • Delivering high doses of radiation with sub-millimeter precision in a non-invasive, non-surgical manner; and
  • Requiring only 1-3 treatment sessions as opposed to 15-30.

“When I read that SRS was non-invasive and completed in 1-3 treatments I knew I had to learn more,” said Laura. “The nearest PetCure Oncology location to me was Cincinnati. I called them the next day and made an appointment.”

In late November, Laura, her father Joe, and Addy made the 8-hour drive from Birmingham to PetCure Oncology at Care Center in Cincinnati. Addy began her SRS treatment on a Wednesday morning and by Thursday afternoon – after just two treatment sessions – they were on the road home.

“Addy did well,” said Laura. “There was no recovery period and no post-treatment wounds. Today she runs around with my sister’s dogs, plays in the backyard and has fun with her toys. The PetCure Oncology team was amazing and willing to help us in every way. This has been a remarkable journey and I know in my heart she has received the best care possible.”

PetCure Oncology has established a network of centers specializing in veterinary SRS across the country. Centers in Phoenix, Cincinnati and Clifton, N.J., are operational. Locations in Wisconsin and Illinois are slated to open in 2016, with many more centers in various stages of development.

For more information: www.petcureoncology.com

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof